open access

Vol 11, No 3 (2017)
Case report
Published online: 2017-12-21
Get Citation

Chronic pain treatment in a cancer survivor — a case study

Magdalena Krzyżak-Jankowicz1, Robert Jankowicz2
Medycyna Paliatywna w Praktyce 2017;11(3):118-121.
Affiliations
  1. Katedra i Klinika Anestezjologii i Intensywnej Terapii, Uniwersytet Medyczny im.Piastów Śląskich we Wrocławiu, Uniwersytecki Szpital Kliniczny, ul. Borowska 213, 50-556 Wrocław, Poland
  2. Hospicjum Domowe, Ośrodek Medycyny Paliatywnej i Hospicyjnej Będkowo Sp. z o.o., Sp.k., Będkowo 1, 55-100 Trzebnica, Poland

open access

Vol 11, No 3 (2017)
Case report
Published online: 2017-12-21

Abstract

Pain in cancer survivors is a major and growing problem. As with all patients, cancer survivors may experience pain from common conditions unrelated to cancer. In addition, survivors may experience comorbid chronic pain acquired or exacerbated during cancer treatment. However, most chronic pain in cancer survivors is treatment related. Chemotherapy, radiotherapy, surgery, hormonal therapy and other treatments, in combination or alone, have the potential to lead to severe persistent pain. This paper presents a case of 61 year-old cancer survivor (from melanoma malignum chorioideae), who was treated with surgery and radiotherapy and as consequence of the management he suffered from chronic facial pain. Pain was managed with oxycodone/naloxon prolonged release tablets, pregabaline and duloxetine with good pain control.

Abstract

Pain in cancer survivors is a major and growing problem. As with all patients, cancer survivors may experience pain from common conditions unrelated to cancer. In addition, survivors may experience comorbid chronic pain acquired or exacerbated during cancer treatment. However, most chronic pain in cancer survivors is treatment related. Chemotherapy, radiotherapy, surgery, hormonal therapy and other treatments, in combination or alone, have the potential to lead to severe persistent pain. This paper presents a case of 61 year-old cancer survivor (from melanoma malignum chorioideae), who was treated with surgery and radiotherapy and as consequence of the management he suffered from chronic facial pain. Pain was managed with oxycodone/naloxon prolonged release tablets, pregabaline and duloxetine with good pain control.
Get Citation

Keywords

pain, pharmacotherapy, oxycodone, pregabaline, duloxetine

About this article
Title

Chronic pain treatment in a cancer survivor — a case study

Journal

Palliative Medicine in Practice

Issue

Vol 11, No 3 (2017)

Article type

Case report

Pages

118-121

Published online

2017-12-21

Page views

555

Article views/downloads

1892

Bibliographic record

Medycyna Paliatywna w Praktyce 2017;11(3):118-121.

Keywords

pain
pharmacotherapy
oxycodone
pregabaline
duloxetine

Authors

Magdalena Krzyżak-Jankowicz
Robert Jankowicz

References (17)
  1. van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007; 18(9): 1437–1449.
  2. Epstein JB, Wilkie DJ, Fischer DJ, et al. Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy. Head Neck Oncol. 2009; 1: 26.
  3. van den Beuken-van Everdingen M. Chronic pain in cancer survivors: a growing issue. J Pain Palliat Care Pharmacother. 2012; 26(4): 385–387.
  4. Brown MRd, Ramirez JD, Farquhar-Smith P. Pain in cancer survivors. Br J Pain. 2014; 8(4): 139–153.
  5. Glare PA, Davies PS, Finlay E, et al. Pain in cancer survivors. J Clin Oncol. 2014; 32(16): 1739–1747.
  6. Bruce J, Quinlan J. Chronic Post Surgical Pain. Rev Pain. 2011; 5(3): 23–29.
  7. Jain Pn, Padole D, Bakshi S. Prevalence of acute neuropathic pain after cancer surgery: A prospective study. Indian J Anaesth. 2014; 58(1): 36–42.
  8. Nguyen MT, Billington A, Habal MB. Osteoradionecrosis of the skull after radiation therapy for invasive carcinoma. J Craniofac Surg. 2011; 22(5): 1677–1681.
  9. Rathy R, Sunil S, Nivia M. Osteoradionecrosis of mandible: Case report with review of literature. Contemp Clin Dent. 2013; 4(2): 251–253.
  10. Delanian S, Chatel C, Porcher R, et al. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial. Int J Radiat Oncol Biol Phys. 2011; 80(3): 832–839.
  11. Paice JA, Portenoy R, Lacchetti C, et al. Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016; 34(27): 3325–3345.
  12. Fallon MT. Neuropathic pain in cancer. Br J Anaesth. 2013; 111(1): 105–111.
  13. Szczudlik A, Dobrogowski J, Wordliczek J, et al. Rozpoznanie i leczenie bólu neuropatycznego: przegląd piśmiennictwa i zalecenia Polskiego Towarzystwa Badania u i Towarzystwa Neurologicznego – część pierwsza. Ból. 2014; 14(2): 8–18.
  14. Szczudlik A, Dobrogowski J, Wordliczek J, et al. Rozpoznanie i leczenie bólu neuropatycznego: przegląd piśmiennictwa i zalecenia Polskiego Towarzystwa Badania u i Towarzystwa Neurologicznego – część druga. Ból. 2014; 14(3): 8–21.
  15. Gatti A, Sabato AF, Occhioni R, et al. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study. Eur Neurol. 2009; 61(3): 129–137.
  16. Semenchuk MR, Sherman S, Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology. 2001; 57(9): 1583–1588.
  17. Semenchuk MR, Davis B. Efficacy of sustained-release bupropion in neuropathic pain: an open-label study. Clin J Pain. 2000; 16(1): 6–11.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl